Anna Martínez‐Cardús

4.4k total citations
48 papers, 1.9k citations indexed

About

Anna Martínez‐Cardús is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Anna Martínez‐Cardús has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 25 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Anna Martínez‐Cardús's work include Colorectal Cancer Treatments and Studies (13 papers), Epigenetics and DNA Methylation (8 papers) and Cancer Genomics and Diagnostics (7 papers). Anna Martínez‐Cardús is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Epigenetics and DNA Methylation (8 papers) and Cancer Genomics and Diagnostics (7 papers). Anna Martínez‐Cardús collaborates with scholars based in Spain, United States and Russia. Anna Martínez‐Cardús's co-authors include Eva Martinez‐Balibrea, Manel Esteller, José Luís Zamora Manzano, Albert Abad, Laura Layos, Cristina Bugés, Sebastián Morán, Alba Ginés, Cátia Moutinho and Sara Bystrup and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anna Martínez‐Cardús

45 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Martínez‐Cardús Spain 23 1.3k 813 487 221 189 48 1.9k
Eva Martinez‐Balibrea Spain 20 937 0.7× 898 1.1× 399 0.8× 237 1.1× 209 1.1× 43 1.7k
Ran Zhao United States 25 1.2k 0.9× 520 0.6× 367 0.8× 156 0.7× 213 1.1× 72 1.7k
Yiding Chen China 21 975 0.8× 710 0.9× 526 1.1× 147 0.7× 247 1.3× 86 2.0k
Mina Maftouh Iran 26 1.2k 1.0× 648 0.8× 752 1.5× 204 0.9× 189 1.0× 39 1.9k
Chandra Bartholomeusz United States 24 1.2k 1.0× 867 1.1× 416 0.9× 140 0.6× 321 1.7× 44 2.0k
Naoise C. Synnott Ireland 13 793 0.6× 706 0.9× 370 0.8× 169 0.8× 235 1.2× 26 1.4k
Lihua Wang China 22 931 0.7× 941 1.2× 536 1.1× 163 0.7× 118 0.6× 70 1.9k
Jun Mao China 24 1.3k 1.1× 523 0.6× 713 1.5× 130 0.6× 117 0.6× 49 1.8k
Noa Rivlin Israel 14 982 0.8× 719 0.9× 459 0.9× 95 0.4× 133 0.7× 15 1.6k
Jonas Cicenas Switzerland 17 921 0.7× 684 0.8× 383 0.8× 137 0.6× 254 1.3× 28 1.5k

Countries citing papers authored by Anna Martínez‐Cardús

Since Specialization
Citations

This map shows the geographic impact of Anna Martínez‐Cardús's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Martínez‐Cardús with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Martínez‐Cardús more than expected).

Fields of papers citing papers by Anna Martínez‐Cardús

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Martínez‐Cardús. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Martínez‐Cardús. The network helps show where Anna Martínez‐Cardús may publish in the future.

Co-authorship network of co-authors of Anna Martínez‐Cardús

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Martínez‐Cardús. A scholar is included among the top collaborators of Anna Martínez‐Cardús based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Martínez‐Cardús. Anna Martínez‐Cardús is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muñoz‐Mármol, Ana M, Bárbara Meléndez, Ainhoa Hernández, et al.. (2025). Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib. Cancers. 17(3). 375–375. 2 indexed citations
2.
3.
Sun, Chen, Aram Boada, Anna Martínez‐Cardús, et al.. (2024). Targeted therapy or immunotherapy in BRAF-mutated metastatic melanoma: a Spanish center’s decade of experience. Frontiers in Oncology. 14. 1322116–1322116. 2 indexed citations
4.
Saigí, Maria, José Luís Mate, Enric Carcereny, et al.. (2024). HLA-I levels correlate with survival outcomes in response to immune checkpoint inhibitors in non-small cell lung cancer. Lung Cancer. 189. 107502–107502. 2 indexed citations
5.
Carcereny, Enric, Maria Saigí, Anna Esteve, et al.. (2023). P1.21-04 Role of HLA-I as a Molecular Prognostic Factor for Long Term Responders in Non-small Cell Lung Cancer Patients Treated with Immunotherapy. Journal of Thoracic Oncology. 18(11). S235–S235. 1 indexed citations
6.
Sun, Chen, et al.. (2023). Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?. Pharmaceutics. 15(3). 823–823. 1 indexed citations
7.
Saigí, Maria, Enric Carcereny, Teresa Morán, et al.. (2022). Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer. Cancer Treatment Reviews. 109. 102430–102430. 6 indexed citations
8.
Capdevila, Jaume, Oriol Arqués, José Ramón Hernández Mora, et al.. (2019). Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas. Clinical Cancer Research. 26(4). 902–909. 28 indexed citations
9.
Oliveira-Mateos, Cristina, Marta Soler, David Piñeyro, et al.. (2019). The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition. Nature Communications. 10(1). 3979–3979. 45 indexed citations
10.
Paz, Alexia Martínez de, David Piñeyro, Anna Martínez‐Cardús, et al.. (2019). Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer. Oncogene. 38(45). 7106–7112. 49 indexed citations
11.
Martínez‐Cardús, Anna, Sebastián Morán, Eva Musulén, et al.. (2016). Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer. Gastroenterology. 151(5). 961–972. 37 indexed citations
12.
Manzano, José Luís Zamora, Laura Layos, Cristina Bugés, et al.. (2016). Resistant mechanisms to BRAF inhibitors in melanoma. Annals of Translational Medicine. 4(12). 237–237. 177 indexed citations
13.
Heyn, Holger, Enrique Vidal, Humberto J. Ferreira, et al.. (2016). Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer. Genome biology. 17(1). 11–11. 152 indexed citations
14.
Porras, Vicenç Ruiz de, Sara Bystrup, Anna Martínez‐Cardús, et al.. (2016). Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway. Scientific Reports. 6(1). 24675–24675. 113 indexed citations
15.
Anadon, Carmen M., Sònia Guil, Laia Simó‐Riudalbas, et al.. (2015). Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene. 35(33). 4407–4413. 95 indexed citations
16.
Martinez‐Balibrea, Eva, Anna Martínez‐Cardús, Alba Ginés, et al.. (2015). Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance. Molecular Cancer Therapeutics. 14(8). 1767–1776. 261 indexed citations
17.
Morán, Sebastián, Miguel Vizoso, Anna Martínez‐Cardús, et al.. (2014). Validation of DNA methylation profiling in formalin-fixed paraffin-embedded samples using the Infinium HumanMethylation450 Microarray. Epigenetics. 9(6). 829–833. 44 indexed citations
18.
Codony‐Servat, Jordi, Xabier García‐Albéniz, Carles Pericay, et al.. (2013). Soluble FAS in the prediction of benefit from cetuximab and irinotecan for patients with advanced colorectal cancer. Medical Oncology. 30(1). 428–428. 4 indexed citations
19.
Martinez‐Balibrea, Eva, Anna Martínez‐Cardús, Eva Musulén, et al.. (2009). Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin‐based chemotherapy. International Journal of Cancer. 124(12). 2905–2910. 60 indexed citations
20.
Plasencia, Carmen, Eva Martinez‐Balibrea, Anna Martínez‐Cardús, et al.. (2006). Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells. International Journal of Oncology. 29(1). 225–35. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Martinez‐Balibrea Breakdown of academic impact, for papers by Ran Zhao Breakdown of academic impact, for papers by Yiding Chen Breakdown of academic impact, for papers by Mina Maftouh Breakdown of academic impact, for papers by Chandra Bartholomeusz Breakdown of academic impact, for papers by Naoise C. Synnott Breakdown of academic impact, for papers by Lihua Wang Breakdown of academic impact, for papers by Jun Mao Breakdown of academic impact, for papers by Noa Rivlin Breakdown of academic impact, for papers by Jonas Cicenas
Rankless by CCL
2026